NCT05423210View on ClinicalTrials.gov

Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 25, 2022

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2029

Conditions
Glioblastoma Multiforme
Interventions
COMBINATION_PRODUCT

Atezolizumab + FSRT radiation

Atezolizumab 840mg IV every 2 weeks Fractionated Stereotactic Radiotherapy

Trial Locations (1)

11794

RECRUITING

Stony Brook University Hospital, Stony Brook

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Stony Brook University

OTHER

NCT05423210 - Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter